Literature DB >> 6435838

Inhibition by 1,25 dihydroxycholecalciferol of hormonal secretion of rat parathyroid gland in organ culture.

W Y Au.   

Abstract

The effect of vitamin D metabolites on parathyroid hormone secretion was studied using rat parathyroid gland cultured in basal medium Eagle containing 5% serum obtained from thyroparathyroidectomized rat, 1 mM magnesium, and calcium concentration varying from 0.75-2.25 mM, and radioimmunoassay for rat parathyroid hormone (rPTH). 1.25 dihydroxycholecalciferol (1,25(OH)2D3), 5 X 10(-10)-2.5 X 10(-8) M, consistently decreased rPTH secretion in dose-related manner; the effect reached steady state after 24 h in vitro addition of 1,25(OH)2D3 and was also observed at different medium calcium concentrations (0.75, 1.25, 1.75 mM). Comparison of dose-responses for inhibitory activity of some vitamin D metabolites on rPTH secretion showed: 1,25(OH)2D3 = 1,24,25(OH)3D3 greater than 1 alpha OHD3 greater than 25 OHD3. Cholecalciferol (10(-5) M), 24,25-dihydroxy-cholecalciferol (10(-8)-10(-6) M) and 25,26-dihydroxy-cholecalciferol (5 X 10(-9)-5 X 10(-7) M) did not inhibit rPTH secretion. Analysis of structural activity relation of vitamin D metabolites studied indicated that 1 alpha or pseudo-1 alpha hydroxylated metabolites or analogs were active in inhibiting rPTH secretion, while, non-1 alpha hydroxylated metabolites were without or were weakly inhibitory only at very high concentrations. This study provides further evidence for a direct role of 1,25(OH)2D3 on a negative feedback loop for regulation of parathyroid gland function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435838     DOI: 10.1007/bf02405350

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  22 in total

1.  Bone-resorbing activity of analogues of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol: effects of side chain modification and stereoisomerization on responses of fetal rat bones in vitro.

Authors:  P H Stern; T Mavreas
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

2.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

3.  Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol.

Authors:  H Rasmussen; M Wong; D Bikle; D B Goodman
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

4.  Effects of vitamin D3 dihydroxylated metabolites on parathyroid hormone in the rat. 'In vitro' studies with dispersed rat parathyroid cells.

Authors:  M Nko; M Gruson; J Gueris; M S Mouktar; J Redel; J Demignon; L Miravet
Journal:  Miner Electrolyte Metab       Date:  1982-02

5.  Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol.

Authors:  B S Chertow; D J Baylink; J E Wergedal; M H Su; A W Norman
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog.

Authors:  J M Canterbury; S Lerman; A J Claflin; H Henry; A Norman; E Reiss
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

7.  Hormone synthesis and secretion by rat parathyroid glands in tissue culture.

Authors:  W Y Au; A P Poland; P H Stern; L G Raisz
Journal:  J Clin Invest       Date:  1970-09       Impact factor: 14.808

8.  Effects of vitamin D metabolites on bovine parathyroid hormone release in vitro.

Authors:  B S Chertow; G R Baker; H L Henry; A W Norman
Journal:  Am J Physiol       Date:  1980-04

9.  Metabolic consequences of oral administration of 24,25-dihydroxycholecalciferol to uremic dogs.

Authors:  J M Canterbury; G Gavellas; J J Bourgoignie; E Reiss
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

10.  Radioimmunoassay of human parathyroid hormone in serum.

Authors:  C D Arnaud; H S Tsao; T Littledike
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  4 in total

1.  Effects of vitamin D3, 25-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion.

Authors:  L K Cantley; J B Russell; D S Lettieri; L M Sherwood
Journal:  Calcif Tissue Int       Date:  1987-07       Impact factor: 4.333

2.  Role of vitamin D metabolites in the prevention of the osteopenia induced by ovariectomy in the axial and appendicular skeleton of the rat.

Authors:  R G Erben; B Kohn; H Weiser; F Sinowatz; W A Rambeck
Journal:  Z Ernahrungswiss       Date:  1990-12

3.  Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats.

Authors:  R G Erben; H Weiser; F Sinowatz; W A Rambeck; H Zucker
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

4.  Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

Authors:  J Silver; T Naveh-Many; H Mayer; H J Schmelzer; M M Popovtzer
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.